4.5 Review

Sandwich-Cultured Hepatocytes as a Tool to Study Drug Disposition and Drug-Induced Liver Injury

期刊

JOURNAL OF PHARMACEUTICAL SCIENCES
卷 105, 期 2, 页码 443-459

出版社

ELSEVIER SCIENCE INC
DOI: 10.1016/j.xphs.2015.11.008

关键词

sandwich-cultured hepatocytes (SCH); hepatic clearance; hepatobiliary disposition; bile acid transporters; toxicity; mathematical models

资金

  1. National Institute of General Medical Sciences of the National Institutes of Health (NIH) [R01 GM041935]

向作者/读者索取更多资源

Sandwich-cultured hepatocytes (SCH) are metabolically competent and have proper localization of basolateral and canalicular transporters with functional bile networks. Therefore, this cellular model is a unique tool that can be used to estimate biliary excretion of compounds. SCH have been used widely to assess hepatobiliary disposition of endogenous and exogenous compounds and metabolites. Mechanistic modeling based on SCH data enables estimation of metabolic and transporter-mediated clearances, which can be used to construct physiologically based pharmacokinetic models for prediction of drug disposition and drug-drug interactions in humans. In addition to pharmacokinetic studies, SCH also have been used to study cytotoxicity and perturbation of biological processes by drugs and hepatically generated metabolites. Human SCH can provide mechanistic insights underlying clinical drug-induced liver injury (DILI). In addition, data generated in SCH can be integrated into systems pharmacology models to predict potential DILI in humans. In this review, applications of SCH in studying hepatobiliary drug disposition and bile acid-mediated DILI are discussed. An example is presented to show how data generated in the SCH model were used to establish a quantitative relationship between intracellular bile acids and cytotoxicity, and how this information was incorporated into a systems pharmacology model for DILI prediction. (C) 2016 American Pharmacists Association (R). Published by Elsevier Inc. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Toxicology

Human variability in isoform-specific UDP-glucuronosyltransferases: markers of acute and chronic exposure, polymorphisms and uncertainty factors

E. E. J. Kasteel, K. Darney, N. Kramer, J. L. C. M. Dorne, L. S. Lautz

ARCHIVES OF TOXICOLOGY (2020)

Article Toxicology

Assessing Effects of BHV-0223 40 mg Zydis Sublingual Formulation and Riluzole 50 mg Oral Tablet on Liver Function Test Parameters Utilizing DILIsym

Diane M. Longo, Lisl K. M. Shoda, Brett A. Howell, Vladimir Coric, Robert M. Berman, Irfan A. Qureshi

TOXICOLOGICAL SCIENCES (2020)

Article Toxicology

Mechanistic Investigations Support Liver Safety of Ubrogepant

Brenda Smith, Josh Rowe, Paul B. Watkins, Messoud Ashina, Jeffrey L. Woodhead, Frank D. Sistare, Peter J. Goadsby

TOXICOLOGICAL SCIENCES (2020)

Article Medicine, Legal

Application of the DILIsym® Quantitative Systems Toxicology drug-induced liver injury model to evaluate the carcinogenic hazard potential of acetaminophen

Gary Eichenbaum, Kyunghee Yang, Yeshitila Gebremichael, Brett A. Howell, F. Jay Murray, David Jacobson-Kram, Hartmut Jaeschke, Edwin Kuffner, Cathy K. Gelotte, John C. K. Lai, Daniele Wikoff, Evren Atillasoy

REGULATORY TOXICOLOGY AND PHARMACOLOGY (2020)

Review Medicine, Legal

A critical review of the acetaminophen preclinical carcinogenicity and tumor promotion data and their implications for its carcinogenic hazard potential

F. Jay Murray, Andrew D. Monnot, David Jacobson-Kram, Samuel M. Cohen, Jerry F. Hardisty, Suren B. Bandara, Michael Kovochich, Milind Deore, Suresh Kumar Pitchaiyan, Cathy K. Gelotte, John C. K. Lai, Evren Atillasoy, Anne Hermanowski-Vosatka, Edwin Kuffner, Kenneth M. Unice, Kyunghee Yang, Yeshitila Gebremichael, Brett A. Howell, Gary Eichenbaum

REGULATORY TOXICOLOGY AND PHARMACOLOGY (2020)

Article Biochemistry & Molecular Biology

QSAR Models for Human Carcinogenicity: An Assessment Based on Oral and Inhalation Slope Factors

Cosimo Toma, Alberto Manganaro, Giuseppa Raitano, Marco Marzo, Domenico Gadaleta, Diego Baderna, Alessandra Roncaglioni, Nynke Kramer, Emilio Benfenati

Summary: This study developed classification and regression models for inhalation and oral slope factors, which showed good accuracy and R^2 values. These models may assist regulatory authorities in decision-making and weighing evidence in chemical safety assessments.

MOLECULES (2021)

Review Toxicology

Effective exposure of chemicals in in vitro cell systems: A review of chemical distribution models

Susana Proenca, Beate Escher, Fabian C. Fischer, Ciaran Fisher, Sebastien Gregoire, Nicky J. Hewitt, Beate Nicol, Alicia Paini, Nynke Kramer

Summary: Nominal effect concentrations from in vitro toxicity assays can lead to inaccurate estimations of in vivo toxic doses. Chemicals distribute differently between in vitro assay compartments, affecting representative concentrations, while free concentrations and cell-associated concentrations can better represent the biologically effective dose.

TOXICOLOGY IN VITRO (2021)

Review Pharmacology & Pharmacy

Vipers of Major clinical relevance in Europe: Taxonomy, venom composition, toxicology and clinical management of human bites

Matteo R. Di Nicola, Andrea Pontara, George E. N. Kass, Nynke Kramer, Ignazio Avella, Riccardo Pampena, Santo Raffaele Mercuri, Jean Lou C. M. Dorne, Giovanni Paolino

Summary: Snakebites in Europe are mainly caused by species of the Vipera genus in the Viperidae family. The venom composition is diverse, leading to various symptoms ranging from pain to tissue damage. Prompt immobilization, compression, and appropriate medical treatment are crucial for managing snakebites effectively.

TOXICOLOGY (2021)

Review Pharmacology & Pharmacy

Safer chemicals using less animals: kick-off of the European ONTOX project

Mathieu Vinken, Emilio Benfenati, Francois Busquet, Jose Castell, Djork-Arne Clevert, Theo M. de Kok, Hubert Dirven, Ellen Fritsche, Liesbet Geris, Rafael Gozalbes, Thomas Hartung, Danyel Jennen, Ramiro Jover, Helena Kandarova, Nynke Kramer, Cyrille Krul, Thomas Luechtefeld, Rosalinde Masereeuw, Erwin Roggen, Stephan Schaller, Tamara Vanhaecke, Chihae Yang, Aldert H. Piersma

Summary: The 3Rs concept, focusing on replacement, reduction, and refinement of animal experimentation, is gaining attention worldwide and has been incorporated into legislation, particularly in the European Union. The ONTOX project in Europe aims to develop AI-driven methods for repeated dose toxicity testing of chemicals without the use of animals to advance human risk assessment. This project will have a significant impact on consolidating Europe's leading position in the development and application of animal-free methods for chemical risk assessment.

TOXICOLOGY (2021)

Article Toxicology

Application of in vitro data in physiologically-based kinetic models for quantitative in vitro-in vivo extrapolation: A case-study for baclofen

Emma E. J. Kasteel, Leonie S. Lautz, Maxime Culot, Nynke Kramer, Anne Zwartsen

Summary: Physiologically-based kinetic (PBK) models can simulate concentrations of chemicals in tissues without the need for animal experiments, but in vivo data are often used to parameterise them. This study demonstrates that a combination of kinetic and dynamic readouts from in vitro assays can be used to parameterise PBK models for neurologically-active chemicals. Using in vitro data, the study successfully predicted concentrations in the central nervous system for different administration routes, showing the accuracy of PBK models without additional in vivo data.

TOXICOLOGY IN VITRO (2021)

Article Environmental Sciences

HiPSC-Derived Hepatocyte-like Cells Can Be Used as a Model for Transcriptomics-Based Study of Chemical Toxicity

Sreya Ghosh, Jonathan De Smedt, Tine Tricot, Susana Proenca, Manoj Kumar, Fatemeharefeh Nami, Thomas Vanwelden, Niels Vidal, Paul Jennings, Nynke I. Kramer, Catherine M. Verfaillie

Summary: Traditional toxicity risk assessment methods have focused on histochemical readouts for cell death, while modern toxicology methods attempt to understand toxicity pathways using transcriptomics and big data-driven approaches. By differentiating human induced pluripotent stem cells into hepatocyte-like cells, researchers were able to accurately classify chemicals causing acute hepatocellular injury and identify stress pathways linked to cytotoxicity. This method may be more sensitive in detecting differentially expressed genes compared to existing datasets, making it suitable for chemical toxicity detection and mechanistic toxicity studies.

TOXICS (2022)

Article Toxicology

Towards best use and regulatory acceptance of generic physiologically based kinetic (PBK) models for in vitro-to-in vivo extrapolation (IVIVE) in chemical risk assessment

Abdulkarim Najjar, Ans Punt, John Wambaugh, Alicia Paini, Corie Ellison, Styliani Fragki, Enrica Bianchi, Fagen Zhang, Joost Westerhout, Dennis Mueller, Hequn Li, Quan Shi, Timothy W. Gant, Phil Botham, Remi Bars, Aldert Piersma, Ben van Ravenzwaay, Nynke I. Kramer

Summary: With the increasing need for new methodologies and the phasing out of animal testing, interpreting in vitro assay results for quantitative hazard characterization is becoming more important. Physiologically based kinetic (PBK) models play a crucial role in extrapolating in vitro concentrations to in vivo exposures. Standardizing PBK modeling approaches is necessary for regulatory risk assessment and several steps are recommended for improvement, including defining context and implementation, harmonizing physiological input parameters, applying Good Modeling Practices (GMP), and evaluating model predictions using alternatives to in vivo data.

ARCHIVES OF TOXICOLOGY (2022)

Article Medicine, Legal

Applicability of generic PBK modelling in chemical hazard assessment: A case study with IndusChemFate

Styliani Fragki, Aldert H. Piersma, Joost Westerhout, Anne Kienhuis, Nynke I. Kramer, Marco J. Zeilmaker

Summary: This article discusses the shift from animal testing to in vitro tools in toxicology research and introduces a quantitative method - kinetic modelling - for assessing chemical safety. The study shows that computational models and in vitro parameters can accurately simulate toxicokinetics.

REGULATORY TOXICOLOGY AND PHARMACOLOGY (2022)

Article Biochemistry & Molecular Biology

Drug Metabolism of Hepatocyte-like Organoids and Their Applicability in In Vitro Toxicity Testing

Manon C. Bouwmeester, Yu Tao, Susana Proenca, Frank G. van Steenbeek, Roos-Anne Samsom, Sandra M. Nijmeijer, Theo Sinnige, Luc J. W. van der Laan, Juliette Legler, Kerstin Schneeberger, Nynke I. Kramer, Bart Spee

Summary: In vitro toxicity testing using hepatocyte-like intrahepatic cholangiocyte organoids (HL-ICOs) allows for the evaluation of drug metabolism gene expression and activity, providing insights into the extent of drug-induced hepatotoxicity.

MOLECULES (2023)

Article Pharmacology & Pharmacy

The effects of hexabromocyclododecane on the transcriptome and hepatic enzyme activity in three human HepaRG-based models

Susana Proenca, Nick van Sabben, Juliette Legler, Jorke H. Kamstra, Nynke I. Kramer

Summary: This study investigates the effects of hexabromocyclododecane (HBCD) on human liver cells using different cell models. The 3D model exhibited the strongest response to HBCD, but none of the models showed changes in enzyme activity related to thyroid hormone metabolism. This suggests that transcriptome changes may not accurately reflect the adverse effects of HBCD on thyroid hormone.

TOXICOLOGY (2023)

暂无数据